Erratum: Tyrosine Hydroxylase Is short-term regulated by the ubiquitin-Proteasome system in PC12 Cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats: Possible implications in hypertension (PLoS ONE (2015) 10:2 (e0116597) DOI: 10.1371/journal.pone.0116597));Tyrosine hydroxylase is short-term regulated by the ubiquitin-proteasome system in PC12 cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats: Possible implications in hypertension

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Longo Carbajosa, Nadia A ^a   Corradi, Gerardo ^a   Lopez Verrilli, María A ^a   Guil, María J ^a   Vatta, Marcelo S ^a   Gironacci, Mariela M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN; LACTACYSTIN; PROTEASOME; TYROSINE 3 MONOOXYGENASE; UBIQUITIN; ACETYLCYSTEINE; PROTEASOME INHIBITOR;

ANIMAL CELL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; HYPERTENSION; HYPOTHALAMUS; MALE; NONHUMAN; PC12 CELL LINE; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; UBIQUITINATION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; NERVE CELL; WISTAR RAT;

RATTUS;

ACETYLCYSTEINE; ANIMALS; BRAIN STEM; HYPERTENSION; HYPOTHALAMUS; MALE; NEURONS; PC12 CELLS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; RATS; RATS, INBRED SHR; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE; UBIQUITIN;

EID: 84923341917     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130785     Document Type: Erratum

References (41)

1. Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin proteasome pathway in normal and disease states. J. Am. Soc. Nephrol. 17: 1807-1819 PMID: 16738015
2. Ciechanover A (2012) Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Neurodegenerative Dis. 10:7-22
3. Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway. Physiol. Rev. 82:373-428 PMID: 11917093
4. Ciechanover A, Brundin P (2003) The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40:427-446 PMID: 14556719
5. Baptista MS, Duarte CB, Maciel P (2012) Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool. Cel. Mol. Life Sci. 69:2691-715 doi: 10.1007/s00018-012-0946-0 PMID: 22382927
6. Zolk O, Schenke C, Sarikas A (2006) The ubiquitin-proteasome system: focus on the heart. Cardiovasc. Res. 70:410-421 PMID: 16497285
7. Stangl K, Stangl V (2010) The ubiquitin-proteasome pathway and endothelial (dys)function. Cardiovasc. Res. 85:281-290 doi: 10.1093/cvr/cvp315 PMID: 19767293
8. Schlossareka S, Carrier L (2011) The ubiquitin-proteasome system in cardiomyopathies. Curr. Opin. Cardiol. 26:190-195 doi: 10.1097/HCO.0b013e32834598fe PMID: 21415726
9. Marfella R, D'Amico M, Di Filippo C, Siniscalchi M, Sasso FC, Ferraraccio F, et al. (2007) The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes. Cardiovasc. Diabetol. 6:35-44 PMID: 17971205
10. Fujisawa H, Okuno S. (2005) Regulatory mechanisms of tyrosine hydroxylase. Biochem. Biophys. Res. Comun. 338: 271-276 PMID: 16105651
11. Reja V, Goodchild AK, Pilowski PM. (2002) Cathecolamine-related gene expression correlates with blood pressures in SHR. Hypertension. 40:342-347 PMID: 12215477
12. 2 receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway. J. Neurochem. 109:326-335 doi: 10.1111/j.1471-4159.2009.05912.x PMID: 19183250
13. Yu K, Lu D, Rowland NE, Raizada MK (1996) Angiotensin II regulation of tyrosine hydroxylase gene expression in the neuronal cultures of normotensive and spontaneously hypertensive rats. Endocrinology 137:3566-3576 PMID: 8754788
14. Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, et al. (2007) Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. Circulation 116:993-1006 PMID: 17698732
15. Wu DK, Cepko CL (1994) The stability of endogenous tyrosine hydroxylase protein in PC-12 cells differs from that expressed in mouse fibroblasts by gene transfer. J. Neurochem. 62:863-872 PMID: 7509376
16. Tank AW, Ham L, Curella P (1986) Induction of tyrosine hydroxylase by cyclic AMP and glucocorticoids in a rat pheochromocytoma cell line: effect of the inducing agents alone or in combination on the enzyme levels and rate of synthesis of tyrosine hydroxylase. Mol. Pharmacol. 30:486-496 PMID: 2430169
17. Fernandez E, Craviso GL (1999) Protein synthesis blockade differentially affects the degradation of constitutive and nicotinic receptor-induced tyrosine hydroxylase protein level in isolated bovine chromaffin cells. J. Neurochem. 73:169-178 PMID: 10386968
18. Nakashima A, Mori K, Kaneko YS, Hayashi N, Nagatsu T, Ota A (2011) Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme. Biochem. Biophys. Res. Comm. 407:343-347 doi: 10.1016/j.bbrc.2011.03.020 PMID: 21392500
19. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Academic Press, New York, USA
20. Lee DH, Goldberg AL (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8: 397-403 PMID: 9789328
21. Yang L, Wang S, Lim G, Sung B, Zeng Q, Mao J (2008) Inhibition of the ubiquitin-proteasome activity prevents glutamate transporter degradation and morphine tolerance. Pain 140: 472-478 doi: 10.1016/j.pain.2008.09.028 PMID: 18986766
22. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Nat. Acad. Sc. USA. 73:2424-2428 PMID: 1065897
23. Uludag H, Sefton MV (1990) Colorimetric assay for cellular activity in microcapsules. Biomaterials. 11:708-712 PMID: 2090308
24. Gironacci MM, Adamo HP, Corradi G, Santos RAS, Ortiz P, Carretero O (2011) Angiotensin-(1-7) induces Mas receptor internalization. Hypertension 58:176-181 doi: 10.1161/HYPERTENSIONAHA.111.173344 PMID: 21670420
25. Zinchuk V, Zinchuk O, Okada T (2007) Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem. Cytochem. 40:101-111 PMID: 17898874
26. Kisselev AF, Akopian TN, Castillo V, Goldberg AL (1999) Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol. Cell. 4:395-402 PMID: 10518220
27. Boutet SC, Disatnik MH, Chan LS, Iori K, Rando TA (2007) Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. Cell. 130:349-362 PMID: 17662948
28. Shabek N, Herman-Bachinsky Y, Buchsbaum S, Lewinson O, Haj-Yahya M, Hejjaoui M, et al. (2012) The size of the proteasomal substrate determines whether its degradation will be mediated by mono- or polyubiquitylation. Mol. Cell. 48:87-97 doi: 10.1016/j.molcel.2012.07.011 PMID: 22902562
29. Erales J, Coffino P (2014) Ubiquitin-independent proteasomal degradation. Biochem. Biophys. Acta. 1843:216-221 doi: 10.1016/j.bbamcr.2013.05.008 PMID: 23684952
30. Dunkley PR, Bobrovskaya L, Graham ME, von Nagy-Felsobuki EI, Dickson PW (2004) Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 91:1025-1043 PMID: 15569247
31. Lehmann IT, Bobrovskaya L, Gordon SL, Dunkley PR, Dickson PW (2006) Differential regulation on the human tyrosine hydroxylase isoforms via hierarchical phosphorylation. J. Biol. Chem. 281:17644-17651 PMID: 16644734
32. Segref A, Hoppe T (2009) Think locally: control of ubiquitin-dependent protein degradation in neurons. EMBO Reports 10:44-50 doi: 10.1038/embor.2008.229 PMID: 19079132
33. Kravtsova-Ivantsiv Y, Ciechanover A (2012) Non-canonical ubiquitin-based signals for proteasomal degradation. J. Cell. Sci. 125:539-548 doi: 10.1242/jcs.093567 PMID: 22389393
34. Døskeland AP, Flatmark T (2002) Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form. Eur. J. Biochem. 269:1561-1569 PMID: 11874472
35. Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch. Biochem. Biophys. 508:1-12 doi: 10.1016/j.abb.2010.12.017 PMID: 21176768
36. Ong LK, Sominsky L, Dickson PW, Hodgson DM, Dunkley PR (2012) The sustained phase of tyrosine hydroxylase activation in vivo. Neurochem. Res. 37:1938-1943 doi: 10.1007/s11064-012-0812-3 PMID: 22684282
37. Kawahata I, Tokuoka H, Parvez H, Ichinose H (2009) Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells. J. Neural Transm. 116:1571-1578 doi: 10.1007/s00702-009-0304-z PMID: 19756365
38. Ludwig A, Fechner M, Wilck N, Meiners S, Grimbo N, Baumann G, et al. (2009) Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system. J. Mol. Med. 87:793-802 doi: 10.1007/s00109-009-0469-9 PMID: 19399470
39. Sakamoto K, Sato Y, Shinka T, Sei M, Nomura I, Umeno M, et al. (2009) Proteasome subunits mRNA expressions correlate with male BMI: implications for a role in obesity. Obesity. 17:1044-1049 doi: 10.1038/oby.2008.612 PMID: 19165168
40. Honcharov SV, Dosenko VI, KhaѤtovych MV, MoѤbenko OO (2009) Allele polymorphism of genes coding proteasome subunits is associated with an enhanced risk for arterial hypertension in adolescents. Fiziol. Zh. 55:3-10 PMID: 20095378
41. Tayebati SK, Tomassoni D, Amenta F (2012) Spontaneously hypertensive rat as a model of vascular brain disorder: microanatomy, neurochemistry and behavior. J. Neurol. Sci. 322:241-249 doi: 10.1016/j.jns.2012.05.047 PMID: 22726353